PSCH vs. BBH
Compare and contrast key facts about Invesco S&P SmallCap Health Care ETF (PSCH) and VanEck Vectors Biotech ETF (BBH).
PSCH and BBH are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. PSCH is a passively managed fund by Invesco that tracks the performance of the S&P SmallCap 600 Health Care Index. It was launched on Apr 7, 2010. BBH is a passively managed fund by VanEck that tracks the performance of the MVIS US Listed Biotech 25 Index. It was launched on Dec 20, 2011. Both PSCH and BBH are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
PSCH vs. BBH - Performance Comparison
Loading graphics...
PSCH vs. BBH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PSCH Invesco S&P SmallCap Health Care ETF | -6.37% | -0.49% | 3.77% | -2.71% | -25.15% | 5.75% | 31.47% | 20.17% | 9.15% | 34.87% |
BBH VanEck Vectors Biotech ETF | 0.04% | 21.18% | -4.29% | 3.94% | -15.25% | 11.81% | 22.13% | 26.34% | -10.70% | 16.46% |
Returns By Period
In the year-to-date period, PSCH achieves a -6.37% return, which is significantly lower than BBH's 0.04% return. Both investments have delivered pretty close results over the past 10 years, with PSCH having a 6.54% annualized return and BBH not far behind at 6.42%.
PSCH
- 1D
- 0.25%
- 1M
- -4.93%
- YTD
- -6.37%
- 6M
- -1.85%
- 1Y
- -2.33%
- 3Y*
- -1.76%
- 5Y*
- -7.33%
- 10Y*
- 6.54%
BBH
- 1D
- 0.70%
- 1M
- -3.58%
- YTD
- 0.04%
- 6M
- 10.55%
- 1Y
- 23.57%
- 3Y*
- 5.92%
- 5Y*
- 1.84%
- 10Y*
- 6.42%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
PSCH vs. BBH - Expense Ratio Comparison
PSCH has a 0.29% expense ratio, which is lower than BBH's 0.35% expense ratio.
Return for Risk
PSCH vs. BBH — Risk / Return Rank
PSCH
BBH
PSCH vs. BBH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco S&P SmallCap Health Care ETF (PSCH) and VanEck Vectors Biotech ETF (BBH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PSCH | BBH | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.10 | 1.05 | -1.15 |
Sortino ratioReturn per unit of downside risk | 0.02 | 1.53 | -1.51 |
Omega ratioGain probability vs. loss probability | 1.00 | 1.20 | -0.20 |
Calmar ratioReturn relative to maximum drawdown | -0.30 | 2.00 | -2.31 |
Martin ratioReturn relative to average drawdown | -0.75 | 5.56 | -6.31 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| PSCH | BBH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.10 | 1.05 | -1.15 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.32 | 0.09 | -0.41 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.28 | 0.29 | -0.01 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.49 | 0.27 | +0.22 |
Correlation
The correlation between PSCH and BBH is 0.69, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
PSCH vs. BBH - Dividend Comparison
PSCH's dividend yield for the trailing twelve months is around 0.01%, less than BBH's 0.51% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PSCH Invesco S&P SmallCap Health Care ETF | 0.01% | 0.04% | 0.27% | 0.01% | 2.27% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.03% | 0.00% |
BBH VanEck Vectors Biotech ETF | 0.51% | 0.51% | 0.80% | 0.43% | 0.47% | 0.21% | 0.36% | 0.34% | 0.50% | 0.55% | 0.30% | 0.27% |
Drawdowns
PSCH vs. BBH - Drawdown Comparison
The maximum PSCH drawdown since its inception was -46.32%, smaller than the maximum BBH drawdown of -72.70%. Use the drawdown chart below to compare losses from any high point for PSCH and BBH.
Loading graphics...
Drawdown Indicators
| PSCH | BBH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -46.32% | -72.70% | +26.38% |
Max Drawdown (1Y)Largest decline over 1 year | -15.36% | -10.47% | -4.89% |
Max Drawdown (5Y)Largest decline over 5 years | -46.32% | -39.86% | -6.46% |
Max Drawdown (10Y)Largest decline over 10 years | -46.32% | -39.86% | -6.46% |
Current DrawdownCurrent decline from peak | -36.16% | -12.15% | -24.01% |
Average DrawdownAverage peak-to-trough decline | -13.26% | -26.05% | +12.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.25% | 3.76% | +2.49% |
Volatility
PSCH vs. BBH - Volatility Comparison
Invesco S&P SmallCap Health Care ETF (PSCH) has a higher volatility of 8.55% compared to VanEck Vectors Biotech ETF (BBH) at 7.01%. This indicates that PSCH's price experiences larger fluctuations and is considered to be riskier than BBH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| PSCH | BBH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.55% | 7.01% | +1.54% |
Volatility (6M)Calculated over the trailing 6-month period | 14.88% | 13.69% | +1.19% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.32% | 22.72% | +0.60% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.91% | 21.47% | +1.44% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.64% | 22.27% | +1.37% |